NOTCH3 and Stroke: Vascular NOTCH3 protein accumulation could be an interesting therapeutic biomarker for CADASIL, as increased vascular NOTCH3 staining and GOM are consistently found in skin arterioles of pre-symptomatic patients, decades before onset of stroke and cognitive decline [18, 19].